101 related articles for article (PubMed ID: 6136545)
1. Changes in cell-surface expression of MHC and Thy-1.2 determinants following treatment with lipid modulating agents.
Muller CP; Stephany DA; Shinitzky M; Wunderlich JR
J Immunol; 1983 Sep; 131(3):1356-62. PubMed ID: 6136545
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Thy-1 alloantibody responses: donor cell-associated H-2 inhibition and augmentation without recipient Ir gene control.
Clark EA; Lake P; Favila-Castillo L
J Immunol; 1981 Nov; 127(5):2135-40. PubMed ID: 6117596
[TBL] [Abstract][Full Text] [Related]
3. Changes in mouse MHC expression during the cell cycle of Con A-treated spleen cells.
Muller CP; Stephany DA; Wunderlich JR
J Immunol; 1986 Jan; 136(1):17-22. PubMed ID: 2415616
[TBL] [Abstract][Full Text] [Related]
4. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl sulfoxide induces expression of H-2 antigens on mouse lung carcinoma cells.
Bahler DW; Lord EM
J Immunol; 1985 Apr; 134(4):2790-8. PubMed ID: 2982954
[TBL] [Abstract][Full Text] [Related]
6. Modulation of B and T cell subsets in mice treated with fractionated total lymphoid irradiation (TLI). IV. Expression of TL4-bearing cells in spleen and bone marrow of TLI-treated mice.
Zan-Bar I
J Immunol; 1983 Oct; 131(4):1683-7. PubMed ID: 6137501
[TBL] [Abstract][Full Text] [Related]
7. T cell lines with dual specificity for strong Mls and H-2 determinants.
Molnar-Kimber KL; Webb SR; Sprent J; Wilson DB
J Immunol; 1980 Dec; 125(6):2643-5. PubMed ID: 6159415
[TBL] [Abstract][Full Text] [Related]
8. The Ir-Thy-1 concept: facts and interpretation.
Zaleski MB; Reichner JS
Surv Immunol Res; 1982; 1(1):76-84. PubMed ID: 6138828
[No Abstract] [Full Text] [Related]
9. Expression of cell surface antigens by suppressor T cell hybridomas. I. Comparison of phenotype and function.
Trial J; Kapp JA; Pierce CW; Shreffler DC; Sorensen CM; Waltenbaugh C
J Immunol; 1983 Feb; 130(2):565-72. PubMed ID: 6217244
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol modulation of membrane fluidity and ecto-nucleotide triphosphatase activity in human normal and CLL lymphocytes.
Deliconstantinos G; Daefler S; Krueger GR
Anticancer Res; 1987; 7(3 Pt B):347-52. PubMed ID: 2957950
[TBL] [Abstract][Full Text] [Related]
11. Serological analysis of H-2 antigens expression on the cell surface of selected mouse tumors.
Opolski A; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(1):7-17. PubMed ID: 3778116
[TBL] [Abstract][Full Text] [Related]
12. Viral antigens act as helper determinants for antibody responses to cell surface antigens.
Bromberg JS; Lake P; Brunswick M
J Immunol; 1982 Aug; 129(2):683-8. PubMed ID: 6177775
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW
J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
Ryan JJ; Mond JJ; Finkelman FD; Scher I
J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
[TBL] [Abstract][Full Text] [Related]
15. Differential glycosylation requirements for the cell surface expression of class I molecules.
Landolfi NF; Rich RR; Cook RG
J Immunol; 1985 Jan; 134(1):423-30. PubMed ID: 3880572
[TBL] [Abstract][Full Text] [Related]
16. Flow microfluorometric analysis of H-2L expression.
Potter TA; Hansen TH; Habbersett R; Ozato K; Ahmed A
J Immunol; 1981 Aug; 127(2):580-4. PubMed ID: 6788845
[TBL] [Abstract][Full Text] [Related]
17. H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes.
Scott JW; Ponzio NM; Orosz CG; Finke JH
J Immunol; 1980 May; 124(5):2378-83. PubMed ID: 6444971
[TBL] [Abstract][Full Text] [Related]
18. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
19. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
20. Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1, and Lyt-2 in congenitally athymic (nu/nu) mice: analysis by flow microfluorometry.
MacDonald HR; Lees RK; Sordat B; Zaech P; Maryanski JL; Bron C
J Immunol; 1981 Mar; 126(3):865-70. PubMed ID: 6970223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
